Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice
about
Understanding the NG2 Glial Scar after Spinal Cord InjurySystemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia.Genetic Ablation of Soluble TNF Does Not Affect Lesion Size and Functional Recovery after Moderate Spinal Cord Injury in Mice.Hippocampal TNFα Signaling Contributes to Seizure Generation in an Infection-Induced Mouse Model of Limbic Epilepsy.Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke.Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling.Essential protective role of tumor necrosis factor receptor 2 in neurodegenerationTrypanosoma brucei growth control by TNF in mammalian host is independent of the soluble form of the cytokine.Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia.The loss-of-function disease-mutation G301R in the Na+/K+-ATPase α2 isoform decreases lesion volume and improves functional outcome after acute spinal cord injury in mice.Unique sensory and motor behavior in Thy1-GFP-M mice before and after spinal cord injury.Nanoparticle-Delivered IRF5 siRNA Facilitates M1 to M2 Transition, Reduces Demyelination and Neurofilament Loss, and Promotes Functional Recovery After Spinal Cord Injury in Mice.Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury.A New Venue of TNF Targeting.Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.
P2860
Q28078778-0C805D57-2E26-474A-913E-62011EBCCF19Q30610169-ACE83F3C-3FB1-4202-ABF3-5EE0187B0C6FQ30833318-959640E3-D2C0-4616-8AA2-D48792591639Q33651396-1793D428-466B-44A5-8022-70271E98F5F6Q36809420-8967AE96-0CAD-4B8A-99B1-E1F83E8FBE29Q37072728-F290367F-ADA1-467D-8D63-ADFAB1FA9779Q37379859-45A79CA1-CA48-494C-B54C-66570A5093E8Q40124235-3E8A7C31-C087-4311-980D-B680E22F8DBCQ41022804-7C86E94F-40EB-4F38-A3E0-C0CA7494DE03Q41526643-643D8678-61F5-4E94-B045-E576395F0B7CQ47828718-56C901D4-CADA-4EBA-A16A-65133E51E2B8Q50199832-587A4341-A61A-4CCC-96F8-D7C6F8511452Q52611789-7E6577AD-C8EC-48D2-97CA-D276D136D2A0Q55001725-F78C38CC-4BAC-494F-A680-CA6C757AE160Q55335193-6D1941A7-3887-4332-A4FC-7E3B25A150AD
P2860
Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in mice
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Central but not systemic admin ...... ate spinal cord injury in mice
@ast
Central but not systemic admin ...... ate spinal cord injury in mice
@en
Central but not systemic admin ...... ate spinal cord injury in mice
@nl
type
label
Central but not systemic admin ...... ate spinal cord injury in mice
@ast
Central but not systemic admin ...... ate spinal cord injury in mice
@en
Central but not systemic admin ...... ate spinal cord injury in mice
@nl
prefLabel
Central but not systemic admin ...... ate spinal cord injury in mice
@ast
Central but not systemic admin ...... ate spinal cord injury in mice
@en
Central but not systemic admin ...... ate spinal cord injury in mice
@nl
P2093
P2860
P50
P1476
Central but not systemic admin ...... ate spinal cord injury in mice
@en
P2093
Anjana Jain
Damien D Pearse
Ditte G Ellman
Erik Runko
Hans G Novrup
John R Bethea
Valerie Bracchi-Ricard
P2860
P2888
P356
10.1186/S12974-014-0159-6
P577
2014-09-10T00:00:00Z
P5875
P6179
1049529992